Biomonitoring-based environmental public health indicators

Methods in Molecular Biology

Volumn 930, Issue , 2013, Pages 275-293

  Egorov, Andrey I ^a   Dalbokova, Dafina ^b   Krzyzanowski, Michal ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Management Consultant   (Bulgaria)

Author keywords

Dioxins; Environment and Health Information System; Environmental public health indicators; Human milk; Persistent organic pollutants; Polybrominated diphenyl ethers; World Health Organization

Indexed keywords

DIOXIN; DIPHENYL ETHER DERIVATIVE;

ARTICLE; BREAST MILK; CHEMISTRY; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; EUROPE; HEALTH STATUS INDICATOR; HUMAN; INFORMATION DISSEMINATION; MEDICAL INFORMATION SYSTEM; METHODOLOGY; POLLUTANT; PUBLIC HEALTH; STATISTICS; WORLD HEALTH ORGANIZATION;

DIOXINS; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; EUROPE; HALOGENATED DIPHENYL ETHERS; HEALTH INFORMATION SYSTEMS; HEALTH STATUS INDICATORS; HUMANS; INFORMATION DISSEMINATION; MILK, HUMAN; PUBLIC HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84870565784     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-059-5_12     Document Type: Article

References (71)

1. Munoz B, Albores A (2010) The role of molecular biology in the biomonitoring of human exposure to chemicals. Int J Mol Sci 11 (11):4511-4525
2. Decordier I, Papine A, Vande Loock K et al (2011) Automated image analysis of micronuclei by IMSTAR for biomonitoring. Mutagenesis 26(1):163-168
3. Rossnerova A, Spatova M, Schunck C et al (2011) Automated scoring of lymphocyte micronuclei by the MetaSystems Metafer image cytometry system and its application in studies of human mutagen sensitivity and biodosimetry of genotoxin exposure. Mutagenesis 26(1):169-175
4. McGeehin MA, Qualters JR, Niskar AS (2004) National environmental public health tracking program: Bridging the information gap. Environ Health Perspect 112(14):1409-1413
5. Esteban M, Castano A (2009) Non-invasive matrices in human biomonitoring: A review. Environ Int 35(2):438-449
6. Paustenbach D, Galbraith D (2006) Biomonitoring and biomarkers: Exposure assessment will never be the same. Environ Health Perspect 114(8):1143-1149
7. Clewell HJ, Tan YM, Campbell JL et al (2008) Andersen ME. Quantitative interpretation of human biomonitoring data. Toxicol Appl Pharmacol 231(1):122-133
8. Sanders T, Liu Y, Buchner V et al (2009) Neurotoxic effects and biomarkers of lead exposure: A review. Rev Environ Health 24 (1):15-45
9. Xu F, Sternberg MR, Markowitz LE (2010) Men who have sex with men in the United States: Demographic and behavioral characteristics and prevalence of HIV and HSV-2-infection: Results from National Health and Nutrition Examination Survey 2001-2006. Sex Transm Dis 37(6):399-405
10. Bate SL, Dollard SC, Cannon MJ (2010) Cytomegalovirus seroprevalence in the United States: The national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 50 (11):1439-1447
11. Markowitz LE, Sternberg M, Dunne EF et al (2009) Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 200 (7):1059-1067
12. Brenner H, Berg G, Lappus N et al (1999) Alcohol consumption and Helicobacter pylori infection: Results from the German National Health and Nutrition Survey. Epidemiology 10(3):214-218
13. Jones JL, Kruszon-Moran D, Sanders-Lewis K et al (2007) Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg 77 (3):405-410
14. Visness CM, London SJ, Daniels JL et al (2009) Association of obesity with IgE levels and allergy symptoms in children and adolescents: Results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol 123(5):1163-1169, 1169.e1-4
15. Branum AM, Lukacs SL (2009) Food allergy among children in the United States. Pediatrics 124(6):1549-1555
16. Miller RL, Garfinkel R, Lendor C et al (2010) Polycyclic aromatic hydrocarbon metabolite levels and pediatric allergy and asthma in an inner-city cohort. Pediatr Allergy Immunol 21 (2 Pt 1):260-267
17. Hui LL, Hedley AJ, Nelson EA et al (2007) Agreement between breast milk dioxin levels by CALUX bioassay and chemical analysis in a population survey in Hong Kong. Chemosphere 69(8):1287-1294
18. Genuis SJ, Birkholz D, Rodushkin I et al (2011) Blood, urine, and sweat (BUS) study: Monitoring and elimination of bioaccumulated toxic elements. Arch Environ Contam Toxicol 61(2):344-357
19. Hu H, Rabinowitz M, Smith D (1998) Bone lead as a biological marker in epidemiologic studies of chronic toxicity: Conceptual paradigms. Environ Health Perspect 106(1):1-8
20. Morris-Cunnington MC, Edmunds WJ, Miller E et al (2004) A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. Am J Epidemiol 159 (8):786-794
21. Griffin SM, Chen IM, Fout GS et al (2011) Development of a multiplexmicrosphere immunoassay for the quantitation of salivary antibody responses to selected waterborne pathogens. J Immunol Methods 364(1-2):83-93
22. Centers for Disease Control and Prevention (2009) Fourth National Report on Human Exposure to Environmental Chemicals. Atlanta, GA, USA
23. Bocca B, Mattei D, Pino A et al (2010) Italian network for human biomonitoring of metals: Preliminary results from two regions. Ann Ist Super Sanita 46(3):259-265
24. Haines DA, Arbuckle TE, Lye E et al (2011) Reporting results of human biomonitoring of environmental chemicals to study participants: A comparison of approaches followed in two Canadian studies. J Epidemiol Community Health 65(3):191-198
25. Bonefeld-Jorgensen EC (2010) Biomonitoring in Greenland: Human biomarkers of exposure and effects-a short review. Rural Remote Health 10(2):1362
26. Rappaport SM (2011) Implications of the exposome for exposure science. J Expo Sci Environ Epidemiol 21(1):5-9
27. Baccarelli A, Giacomini SM, Corbetta C et al (2008) Neonatal thyroid function in Seveso 25 years after maternal exposure to dioxin. PLoS Med 5(7):e161
28. Boogaard PJ, Hays SM, Aylward LL (2011) Human biomonitoring as a pragmatic tool to support health risk management of chemicals-Examples under the EU REACH programme. Regul Toxicol Pharmacol 59 (1):125-132
29. Aylward LL, Lakind JS, Hays SM (2008) Derivation of biomonitoring equivalent (BE) values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds: A screening tool for interpretation of biomonitoring data in a risk assessment context. J Toxicol Environ Health A 71(22):1499-1508
30. Ruiz P, Fowler BA, Osterloh JD et al (2010) Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants-metals. SAR QSAR Environ Res 21(7-8):603-618
31. Ritter R, Scheringer M, Macleod M et al (2011) Intrinsic human elimination half-lives of polychlorinated biphenyls derived from the temporal evolution of cross-sectional biomonitoring data from the UK population. Environ Health Perspect 119(2):225-231
32. Heinzl H, Mittlbock M, Edler L (2007) On the translation of uncertainty from toxicokinetic to toxicodynamic models-the TCDD example. Chemosphere 67(9):S365-S374
33. Aylward LL, Brunet RC, Carrier G et al (2005) Concentration-dependent TCDD elimination kinetics in humans: Toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J Expo Anal Environ Epidemiol 15(1):51-65
34. Aylward LL, Brunet RC, Starr TB et al (2005) Exposure reconstruction for the TCDDexposed NIOSH cohort using a concentrationand age-dependent model of elimination. Risk Anal 25(4):945-956
35. Cheng H, Aylward L, Beall C et al (2006) TCDD exposure-response analysis and risk assessment. Risk Anal 26(4):1059-1071
36. Corvalan C, Kjellstrom T, Smith KR (1999) Health, environment and sustainable development: Identifying links and indicators to promote action. Epidemiology 10(5):656-660
37. Pond K, Kim R, Carroquino MJ et al (2007) Workgroup report: Developing environmental health indicators for European children: World Health Organization Working Group. Environ Health Perspect 115(9):1376-1382
38. World Health Organization (2007) Children's health and the environment in Europe. A baseline assessment report. World Health Organization Regional Office for Europe, Copenhagen, http://www.euro.who.int/-data/assets/pdf-file/0009/ 96750/ E90767.pdf. Accessed 04 Jul 2012
39. World Health Organization (2010) Health and environment in Europe: Progress assessment. World Health Organization Regional Office for Europe, Copenhagen, http://www.euro. who.int/-data/assets/pdf-file/0010/96463/E93556. pdf. Accessed 04 Jul 2012
40. World Health Organization (2010) Parma declaration on environment and health. EUR/ 55934/5.1. World Health Organization Regional Office for Europe, Copenhagen, http://www.euro.who.int/en/home/confer ences/fifth-ministerial- conference-on-environment-and-health/documentation/ parma-declaration-on- environment-andhealth. Accessed 5 Dec 2010
41. World Health Organization (2007) Fourth WHO-coordinated survey of human milk for persistent organic pollutants in cooperation with UNEP. Guidelines for developing a national protocol. World Health Organization, Geneva, http://www.who.int/foodsafety/ chem/POPprotocol.pdf. Accessed 04 Jul 2012
42. Malisch R, Moy G (2006) Fourth round of WHO-coordinated exposure studies on levels of persistent organic pollutants in human milk. Organohalogen Compd 68:1627-1630
43. Malisch R, Kypke K, Kotz A et al (2010) WHO/UNEP-coordinated exposure study (2008-2009) on levels of persistent organic pollutants (POPs) in human milk with regard to the global monitoring plan. 30th International symposium on halogenated organic pollutants, San Antonio Texas, USA
44. Colles A, Koppen G, Hanot V et al (2008) Fourth WHO-coordinated survey of human milk for persistent organic pollutants (POPs): Belgian results. Chemosphere 73(6):907-914
45. Lundén A, Norén K (1998) Polychlorinated naphthalenes and other organochlorine contaminants in Swedish human milk, 1972-1992. Arch Environ Contam Toxicol 34(4): 414-423
46. Norén K, Meironyté D (2000) Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20-30 years. Chemosphere 40(9-11): 1111-1123
47. Lind Y, Darnerud PO, Atuma S et al (2003) Polybrominated diphenyl ethers in breast milk from Uppsala County, Sweden. Environ Res 93 (2):186-194
48. Foster WG, Maharaj-Briceno S, Cyr DG (2010) Dioxin-induced changes in epididymal sperm count and spermatogenesis. Environ Health Perspect 118(4):458-464
49. World Health Organization (2002) Evaluation of certain food additives and contaminants: Fiftyseventh report of the joint FAO/WHO expert committee on food additives. World technical report series 909. World Health Organization, Geneva, http://whqlibdoc.who.int/trs/WHO-TRS-909.pdf. Accessed 04 Jul 2012
50. Svechnikov K, Izzo G, Landreh L et al (2010) Endocrine disruptors and Leydig cell function. J Biomed Biotechnol pii:684504
51. Mocarelli P, Gerthoux PM, Patterson DG Jr et al (2008) Dioxin exposure, from infancy through puberty, produces endocrine disruption and affects human semen quality. Environ Health Perspect 116(1):70-77
52. Matés JM, Segura JA, Alonso FJ et al (2010) Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms. Free Radic Biol Med 49 (9):1328-1341
53. Joint WHO/Convention task force on the health aspects of air pollution (2003) Health risks of persistent organic pollutants from longrange transboundary air pollution. World Health Organization, Geneva 54. European Commission. Health and Consumer Protection Directorate-General (2000) Opinion of the Scientific Committee on animal nutrition on the dioxin contamination of feedstuffs and their contribution to the contamination of food of animal origin. http://ec.europa. eu/food/committees/scientific/out55-en. pdf. Accessed 10 March 2011
54. Patandin S, Dagnelie PC, Mulder PG et al (1999) Dietary exposure to polychlorinated biphenyls and dioxins from infancy until adulthood: A comparison between breast-feeding, toddler, and long-term exposure. Environ Health Perspect 107(1):45-51
55. Van den Berg M, Birnbaum L, Bosveld AT et al (1998) Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 106 (12):775-792
56. Van den Berg M, Birnbaum LS, Denison M et al (2006) The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93 (2):223-241
57. Aylward LL, Lamb JC, Lewis SC (2005) Issues in risk assessment for developmental effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Toxicol Sci 87(1):3-10
58. Gray MN, Aylward LL, Keenan RE (2006) Relative cancer potencies of selected dioxinlike compounds on a body-burden basis: Comparison to current toxic equivalency factors (TEFs). J Toxicol Environ Health A 69 (10):907-917
59. World Health Organization (2000) Assessment of the health risk of dioxin: Re-evaluation of the tolerable daily intake (TDI): Executive summary. Food Add Contam 17:223-240
60. De Mul A, Bakker MI, Zeilmaker MJ et al (2004) Dietary exposure to dioxins and dioxin-like PCBs in The Netherlands anno 2004. Regul Toxicol Pharmacol 51 (3):278-287
61. Gies A, Neumeier G, RappolderMet al (2007) Risk assessment of dioxins and dioxin-like PCBs in food-Comments by the German Federal Environmental Agency. Chemosphere 67(9):S344-S349
62. Kiviranta H, Tuomisto JT, Tuomisto J et al (2005) Polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in the general population in Finland. Chemosphere 60 (7):854-869
63. Kiviranta H, Vartiainen T, Tuomisto J (2002) Polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in fishermen in Finland. Environ Health Perspect 110(4):355-361
64. Dewey KG, Heinig MJ, Nommsen LA et al (1991) Adequacy of energy intake among breast-fed infants in the DARLING study: Relationships to growth velocity, morbidity, and activity levels. Davis area research on lactation, infant nutrition and growth. J Pediatr 119 (4):538-547
65. Birnbaum LS, Cohen Hubal EA (2006) Polybrominated diphenyl ethers: A case study for using biomonitoring data to address risk assessment questions. Environ Health Perspect 114 (11):1770-1775
66. Schecter A, Pavuk M, Papke O et al (2003) Polybrominated diphenyl ethers (PBDEs) in U.S. mothers' milk. Environ Health Perspect 111(14):1723-1729
67. Main KM, Kiviranta H, Virtanen HE et al (2007) Flame retardants in placenta and breast milk and cryptorchidism in newborn boys. Environ Health Perspect 115(10):1519-1526
68. US EPA (2008) Final integrated risk information system assessment for decabromodiphenyl ether (BDE-209). http://www.epa.gov/ncea/ iris/subst/0035.htm. Accessed 10 Jan 2011
69. Directive 2003/11/EC of the European Parliament and of the Council of 6 February 2003 amending the for the 24th time Council Directive 76/769/EEC relating to restrictions on the marketing and use of certain dangerous substances and preparations (pentabromodiphenyl ether, octabromodiphenyl ether). 2003. Official Journal of the European Union. http://eur-lex. europa.eu/LexUriServ/site/en/oj/2003/l-042/l-04220030215en00450046.pdf. Accessed 04 Jul 2012
70. Pakalin S, Cole T, Steinkellner J et al (2007) Review on production processes of decabromodiphenyl ether (decaBDE) used in polymeric applications in electrical and electronic equipment, and assessment of the availability of potential alternatives to decaBDE. European Commission. Directorate-General Joint Research Centre, Institute of Health and Consumer Protection, European Chemicals Bureau, Ispra, Italy. EUR 22693 EN
71. Pruss-Ustun A, Vickers C, Haefliger P et al (2011) Knowns and unknowns on burden of disease due to chemicals: A systematic review. Environ Health 10(1):9